mail2

Spectrum Library

Monitoring neuromyelitis optica activity. [Expert Rev Neurother. 2013] – PubMed – NCBI

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica

Publication Date December 2012

Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis

Publication Date December 2012

Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels

Publication Date January 2013

Increased plasma interleukin-32 expression in patients with neuromyelitis optica

Publication Date November 2012

Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica

Publication Date December 2012

The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies

Publication Date December 2012

Neuromyelitis optica spectrum disorder: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography findings–case report

Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system

Publication Date January 2013

Evaluation of new immunological targets in neuromyelitis optica

Publication Date November 2012

Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica

Publication Date October 2012

Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis

Publication Date November 2012

Launch Dashboard

Dashboard

Fast Facts about NMOSD

NMOSD Symptoms Treatment Relapse Diagnosis Doctors Research News Advocate Helpline Resilience Events